Prognostic impact of <i>HER‐2/neu</i> expression on squamous head and neck carcinomas

Abstract

HER2/neu overexpression and its relationship with survival suggest that new therapeutic approaches targeting epidermal growth factor receptor (EGFR) family receptors could provide a new way of treating HNSCC patients with HER2/neu-positive neoplastic lesions.